Orexin B inhibits proliferation and stimulates specialized function of cultured rat calvarial osteoblast-like cells

International Journal of Molecular Medicine

Volumn 22, Issue 6, 2008, Pages 749-755

  Ziolkowska, Agnieszka ^a   Rucinski, Marcin ^a   Tyczewska, Marianna ^a   Malendowicz, Ludwik K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Immunofluorescence; Orexin, orexin receptor; Osteocalcin; Proliferation; QPCR; Rat calvarial osteoblast like cells

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN B; OSTEOCALCIN; OSTEONECTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALVARIA; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; OSTEOBLASTS; OSTEOCALCIN; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; SKULL;

EID: 65449131670     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000081     Document Type: Article

References (62)

1. Sakurai T, Ameniaya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JRS, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ and Yanagisawa M: Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585, 1998.
2. De Lecea L, Kilduff T, Peyron C, Gao X, Foye P, Danielson P, Fukuhara C, Battenberg E, Gautvik V, Bartlett F, Frankel W, Van den Pol A, Bloom F, Gautvik K and Sutcliffe J: The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95: 322-327, 1998.
3. Sakurai T: Orexins: a newly discovered family of hypothalamic regulators of food intake. Regul Pept 85: 25-30, 1999.
4. Sakurai T: Roles of orexins and orexin receptors in central regulation of feeding behavior and energy homeostasis. CNS Neurol Disord Drug Targets 5: 313-325, 2006.
5. Willie JT, Chemelli RM, Sinton CM and Yanagisawa M: To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 24: 429-458, 2001.
6. Kukkonen JP, Holmqvist T, Ammoun S and Akerman KE: Functions of the orexinergic/hypocretinergic system. Am J Physiol Cell Physiol 283: C1567-C1591, 2002.
7. Wang J, Osaka T and Inoue S: Orexin-A-sensitive site for energy expenditure localized in the arcuate nucleus of the hypothalamus. Brain Res 971: 128-134, 2003.
8. Manolagas SC: Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21: 115-137, 2000.
9. Elefteriou F: Neuronal signaling and the regulation of bone remodeling. Cell Mol Life Sci 62: 2339-2349, 2005.
10. Ziolkowska A, Rucinski M, Tortorella C, Tyczewska M, Nussdorfer GG and Malendowicz LK: Cultured rat calvarial osteoblast-like cells are provided with orexin type 1 receptors. Int J Mol Med 20: 779-782, 2007.
11. Boden SC, McCuaig K, Hair G, Racine M, Titus L, Wozney JM and Nanes MS: Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 137: 3401-3407, 1996.
12. Bodine PV and Komm BS: Tissue culture models for studies of hormone and vitamin action in bone cells. Vitam Horm 64: 101-151, 2002.
13. Kartsogiannis V and Ng KW: Cell lines and primary cell cultures in the study of bone cell biology. Mol Cell Endocrinol 228: 79-102, 2004.
14. Ziolkowska A, Rucinski M, Pucher A, Nussdorfer GG and Malendowicz LK: Expression of osteoblast marker genes in rats calvarial osteoblast-like cells, and effects of the endocrine disrupters diphenylolpropane, benzophenone-3, resveratrol and silymarin. Chem Biol Interact 164: 147-156, 2006.
15. Mossmann T: Rapid colorimetric assay of cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
16. Albertin G, Carraro G, Parnigotto PP, Conconi MT, Ziolkowska A, Malendowicz LK and Nussdorfer GG: Human skin keratinocytes and fibroblasts express adrenomedullin and its receptors, and adrenomedullin enhances their growth in vitro by stimulating proliferation and inhibiting apoptosis. Int J Mol Med 11: 635-639, 2003.
17. Tortorella C, Macchi C, Spinazzi R, Malendowicz LK, Trejter M and Nussdorfer GG: Ghrelin, an endogenous ligand for the growth hormone-secretagogue receptor, is expressed in the human adrenal cortex. Int J Mol Med 12: 213-217, 2003.
18. Ziolkowska A, Rucinski M, Neri G, Di Liddo R, Nussdorfer GG and Malendowicz LK: Expression of the beacon gene in the rat adrenal gland: Direct inhibitory effect of beacon[47-73] on aldosterone secretion from dispersed adrenal zona glomerulosa cells. Int J Mol Med 13: 215-219, 2004.
19. Rucinski M, Andreis PG, Ziolkowska A, Nussdorfer GG and Malendowicz LK: Differential expression and function of beacon in the rat adrenal cortex and medulla. Int J Mol Med 16: 35-40, 2005.
20. Rucinski M, Ziolkowska A, Neri G, Trejter M, Zemleduch T, Tyczewska M, Nussdorfer GG and Malendowicz LK: Expression of neuromedins S and U and their receptors in the hypothalamus and endocrine glands in rat. Int J Mol Med 20: 255-259, 2007.
21. Bhargava U, Bar-Lev M, Bellows CG and Aubin JE: Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells. Bone 9: 155-163, 1988.
22. Aubin JE, Liu F, Malaval L and Gupta AK: Osteoblast and chondroblast differentiation. Bone 17: S77-S83, 1995.
23. Mundy GR: Local control of bone formation by osteoblasts. Clin Orthop Relat Res 313: 19-26, 1995.
24. Hinoi E, Fujimori S, Nakamura Y and Yoneda Y: Group III metabotropic glutamate receptors in at cultured calvarial osteoblasts. Biochem Biophys Res Commun 281: 341-346, 2001.
25. Hinoi E, Fujimori S, Takemori A and Yoneda Y: Cell death by pyruvate deficiency in proliferative cultured calvarial osteoblasts. Biochem Biophys Res Commun 294: 1177-1183, 2002.
26. Tsukamoto Y, Ishihara Y, Miyagawa-Tomita S and Hagiwara H: Inhibition of ossification in vivo and differentiation of osteoblasts in vitro by tributyltin. Biochem Pharmacol 68: 739-746, 2004.
27. Pockwinse SM, Wilming LG, Conlon DM, Stein GS and Lian JB: Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue-like organization in primary osteoblast cultures. J Cell Biochem 49: 310-323, 1992.
28. Pockwinse SM, Stein JL, Lian JB and Stein GS: Developmental stage-specific cellular responses to vitamin D and glucocorticoids during differentiation of the osteoblast phenotype: interrelationship of morphology and gene expression by in situ hybridization. Exp Cell Res 216: 244-260, 1995.
29. Hauschka PV, Lian JB, Cole DEC and Gundberg CM: Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69: 990-1047, 1989.
30. Plant A and Tobias JH: Characterization of the temporal sequence of osteoblast gene expression during estrogen-induced osteogenesis in female mice. J Cell Biochem 82: 683-691, 2001.
31. Rucinski M, Ziolkowska A, Hochol A, Pucher A, Macchi C, Belloni AS, Nussdorfer GG and Malendowicz LK: Estradiol and resveratrol stimulating effect on osteocalcin, but not osteonectin and collagen-1alpha gene expression in primary culture of rat calvarial osteoblast-like cells. Int J Mol Med 18: 565-570, 2006.
32. Lagumdzija A, Bucht E, Stark A, Hulting AL and Petersson M: Arg-vasopressin increases proliferation of human osteoblast-like cells and decreases production of interleukin-6 and macrophage colony-stimulating factor. Regul Pept 121: 41-48, 2004.
33. Lagumdzija A, Pernow Y, Bucht E, Gonon A and Petersson M: The effects of arg-vasopressin on osteoblast-like cells in endothelial nitric oxide synthase-knockout mice and their wild type counterparts. Peptides 26: 1661-1666, 2005.
34. Bjurholm A, Kreickbergs A, Schultzberg M and Lerner UH: Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells. J Bone Miner Res 7: 1011-1019, 1992.
35. Goto T, Nakao K, Gunjigake KK, Kido MA, Kobayashi S and Tanaka T: Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors. Neuropeptides 41: 25-31, 2007.
36. Togari A, Arai M, Mizutani S, Mizutani S, Koshihara Y and Nagatsu T: Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci Lett 233: 125-128, 1997.
37. Lundberg P, Boström I, Mukohyama H, Bjurholm A, Smans K and Lerner UH: Neuro-hormonal control of bone metabolism: vasoactive intestinal peptide stimulates alkaline phosphatase activity and mRNA expression in mouse calvarial osteoblasts as well as calcium accumulation mineralized bone nodules. Regul Pept 85: 47-58, 1999.
38. Lundberg P, Lie A, Bjurholm A, Lehenkari PP, Horton MA, Lerner UH and Ransjö M: Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts. Bone 27: 803-810, 2000.
39. Lundberg P, Lundgren I, Mukohyama H, Lehenkari PP, Horton MA and Lerner UH: Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors. Endocrinology 142: 339-347, 2001.
40. Bollag RJ, Zhong Q, Phillips P, Min L, Zhong L, Cameron R, Mulloy AL, Rasmussen H, Qin F, Ding KH and Isales CM: Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 141: 1228-1235, 2000.
41. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P and Karsenty G: Endocrine regulation of energy metabolism by the skeleton. Cell 130: 456-469, 2007.
42. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM and Karsenty G: Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100: 197-207, 2000.
43. Takeda S: Central control of bone remodeling. Biochem Biophys Res Commun 328: 697-699, 2005.
44. Karsenty G: Convergence between bone and energy homeostases: Leptin regulation of bone mass. Cell Metab 4: 341-348, 2006.
45. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B and Riggs BL: Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140: 1630-1638, 1999.
46. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO and Drevon CA: Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16: 1426-1433, 2001.
47. Gordeladze JO, Drevon CA, Syversen U and Reseland JE: Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 85: 825-836, 2002.
48. Iwamoto I, Fujino T and Douchi T: The leptin receptor in human osteoblasts and the direct effect of leptin on bone metabolism. Gynecol Endocrinol 19: 97-104, 2004.
49. Lee YJ, Park JH, Ju SK, You KH, Ko JS and Kim HM: Leptin receptor isoform expression in rat osteoblasts and their functional analysis. FEBS Lett 528: 43-47, 2002.
50. Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Myers DE, Nicholson GC and Reid IR: Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175: 405-415, 2002.
51. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM and Herzog H: Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109: 915-921, 2002.
52. Baldock PA, Sainsbury A, Allison S, Lin EJ, Couzens M, Boey D, Enriquez R, During M, Herzog H and Gardiner EM: Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways. J Bone Miner Res 20: 1851-1857, 2005.
53. Baldock PA, Allison SJ, Lundberg P, Lee NJ, Slack K, Lin EJ, Enriquez RF, McDonald MM, Zhang L, During MJ, Little DG, Eisman JA, Gardiner EM, Yulyaningsih E, Lin S, Sainsbury A and Herzog H: Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J Biol Chem 282: 19092-19102, 2007.
54. Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M, Inose H, Ida T, Mieda M, Takeuchi Y, Fukumoto S, Fujita T, Kato S, Kangawa K, Kojima M, Shinomiya K and Takeda S: Central control of bone remodeling by neuromedin U. Nat Med 10: 1234-1240, 2007.
55. Rucinski M, Ziolkowska A, Tyczewska M, Szyszka M and Malendowicz LK: Neuromedin U directly stimulates growth of cultured rat calvarial osteoblast-like cells acting via the NMU receptor 2 isoform. Int J Mol Med 22: 22: 363-368, 2008.
56. Nefussi JR, Brami G, Modrowski D, Oboeuf M and Forest N: Sequential expression of bone matrix proteins during rat calvaria osteoblast differentiation and bone nodule formation in vitro. J Histochem Cytochem 45: 493-503, 1997.
57. Sharma P, Solomon KR and Hauschka PV: High-throughput tool for discovery of bone regulating factors. Biotechniques 41: 539-542, 2006.
58. Higuchi S, Usui A, Murasaki M, Matsushita S, Nishioka N, Yoshino A, Matsui T, Muraoka H, Ishizuka Y, Kanba S and Sakurai T: Plasma orexin-A is lower in patients with narcolepsy. Neurosci Lett 318: 61-64, 2002.
59. Nishijima T, Sakurai S, Arihara Z and Takahashi K: Plasma orexin-A-like immunoreactivity in patients with sleep apnea hypopnea syndrome. Peptides 24: 407-411, 2003.
60. Kappeler L, Zizzari P, Grouselle D, Epelbaum J and Bluet-Pajot MT: Plasma and hypothalamic peptide-hormone levels regulating somatotroph function and energy balance in fed and fasted states: a comparative study in four strains of rats. J Neuroendocrinol 16: 980-988, 2004.
61. Lin J, Yan GT, Hao XH, Zhang K, Wang LH and Xue H: Establishment and primary application of a highly-sensitive orexin-A radioimmunoassay. J Immunoassay Immunochem 25: 45-55, 2004.
62. Katayama Y, Hirai K, Homma T, Noda Y and Honda K: Actions of orexins on individual myenteric neurons of the guinea-pig ileum: orexin A or B? Neuroreport 16: 745-749, 2005.